![Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days]({"type":"image" , "src" : "/sda/5925/TOC-Subject-Sample-2021-Bioscience.jpg"})
Abstract
The human body has adapted to defend against the aggressive biological or chemical agents. As a result, the defence mechanisms of the human body became barriers for the drug delivery. Theoretically, any problem that prevents a drug from reaching its site of action is considered to be a barrier to drug delivery. The aim of this article is to discuss the possibility of three types of nanocarriers (nanoparticles, liposomes, and solid lipid nanoparticles) to help the drugs to pass some important biological barriers (blood–brain barriers, skin, eye, and tumors) using different strategies/designs of drug delivery systems.
Acknowledgements
Declaration of interest: The following research grant was received: CNCSIS - PN II - IDEI - 708/2009.
The Early Online version of this article published online ahead of print on 2 November 2009 contained an error in the declaration of interest section. The declaration of interest should read: The following research grant was received: CNCSIS - PN II - IDEI - 708/2009. The corrected version will feature in issue GDRT 18(4).